In a recent paper published in Cell,Wang et al.report that deficiency of triggering receptor expressed on myeloid cells 2 (TREM2) augments amyloid β accumulation and neuronal loss in a mouse model of Alzheimer's disease.TREM2 acts as a signaling receptor involved in innate immunity for the natural clearance of this toxic protein by microglia.